Company intelligence / Profile preview

Chongqing Talents Pharmaceutical

Chongqing, Chongqing, China

Ownership: Private
Employees: ~1000
Development stage: Other

Overview

Chongqing Pharscin Pharmaceutical has a commercial portfolio with 68 product approvals, including innovative Chinese patent medicines and the first generics for several indications. The company has notable achievements in R&D and holds substantial experience in combining Chinese and Western medicine technologies. Many products are included in China's National Medical Insurance catalog, and the company continues to expand its clinical and R&D pipeline in chronic, cardiovascular, metabolic, immunological, and oncology areas.

Therapeutic areas: ImmunologyMetabolic DisordersGastroenterologyCardiovascularOtherOncologyNeurology
Modalities: Small moleculeTraditional Chinese medicineBiologic
Industry: Biotech

Beyond the preview

Go deeper on Chongqing Talents Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Chongqing Talents Pharmaceutical.

Explore the full profile